tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
:DRUG
Canadian Market
DRUG
Bright Minds Biosciences
RESEARCH TOOLSreports
Want to see TSE:DRUG full AI Analyst Report?

Bright Minds Biosciences (DRUG) Stock News & Sentiment

72 Followers
Buy Rating on BMB-101 Driven by Strong Phase 2 Epilepsy Data, Differentiated Safety, and Prader–Willi Upside Supporting DCF Valuation
Premium
Ratings
Buy Rating on BMB-101 Driven by Strong Phase 2 Epilepsy Data, Differentiated Safety, and Prader–Willi Upside Supporting DCF Valuation
18d ago
DRUG
Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
Premium
Ratings
Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
2M ago
DRUG
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
Premium
Ratings
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
2M ago
DRUG
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
Premium
Company Announcements
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
2M ago
6K
DRUG
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
Premium
Company Announcements
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
3M ago
6K
DRUG
Bright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
Premium
Company Announcements
Bright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
3M ago
6K
DRUG
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
Premium
Company Announcements
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
3M ago
6K
DRUG
More TSE:DRUG News >

DRUG News on the Web

Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
TipRanks News
Bullish
Bright Minds initiated with a Buy at Jefferies
TipRanks News
Bullish
Buy Rating on BMB-101 Driven by Strong Phase 2 Epilepsy Data, Differentiated Safety, and Prader–Willi Upside Supporting DCF Valuation
TipRanks News
Bullish
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
TipRanks News
Bullish
Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript
GuruFocus News
Neutral
DRUG: HC Wainwright & Co. Raises Price Target to $145, Maintains Buy Rating | DRUG Stock News
GuruFocus News
Bullish
Bright Minds price target raised to $145 from $115 at H.C. Wainwright
TipRanks News
Bullish
Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
TipRanks News
Bullish

News Score - Last 7 Days

Positive
TSE:DRUG
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:DRUG’s Media Buzz Sentiment?
2 articles about TSE:DRUG were published this week. In an average week, 1 articles are published.
    What is TSE:DRUG’s weekly average amount of articles?
    In an average week, 1 articles about TSE:DRUG are published.
      What is TSE:DRUG’s News Sentiment?
      100% of articles about TSE:DRUG were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        REPLReplimune Group
        RVMDRevolution Medicines
        HVOOpen Orphan Plc
        Showing the stocks with the most bullish news sentiment over the past week